Role of ultrasonography in the evaluation of disease severity and treatment efficacy in adenomyosis
- PMID: 37115275
- DOI: 10.1007/s00404-023-07034-4
Role of ultrasonography in the evaluation of disease severity and treatment efficacy in adenomyosis
Abstract
Background: Adenomyosis is a benign disorder characterized by the presence of ectopic endometrial glands and stroma within the myometrium. The main clinical manifestations of adenomyosis are dysmenorrhea, menorrhagia, and infertility, which affect patients' quality of life. Recently, with advancements in imaging techniques, magnetic resonance imaging, and ultrasonography have become the main diagnostic tools for adenomyosis. In addition to the diagnosis and differential diagnosis of adenomyosis, ultrasonography can also be used to evaluate the severity of adenomyosis. The emergence of new techniques, such as elastography and contrast-enhanced ultrasonography (CEUS), has significantly improved the accuracy of ultrasound-based diagnosis of adenomyosis. These two imaging tools can also be used for the differential diagnosis of adenomyosis and the evaluation of treatment efficacy after medication or ablation procedure.
Objective: we review the efficacy of ultrasonography as a diagnostic tool for adenomyosis. We also aim to introduce the potential of ultrasound imaging in the evaluation of the severity of this disease, as well as the application of elastography and contrast-enhanced ultrasonography (CEUS) in its diagnosis.
Results and conclusion: Our findings reveal the potential value of ultrasonography combined with elastography and/or CEUS as medication guidance and efficacy evaluation tools in the long-term management of adenomyosis.
Keywords: Adenomyosis; Contrast-enhanced ultrasonography; Elastography; Transvaginal ultrasonography.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Diagnosing adenomyosis: an integrated clinical and imaging approach.Hum Reprod Update. 2020 Apr 15;26(3):392-411. doi: 10.1093/humupd/dmz049. Hum Reprod Update. 2020. PMID: 32097456 Review.
-
Use of contrast-enhanced ultrasound in evaluating the efficacy and application value of microwave ablation for adenomyosis.J Cancer Res Ther. 2020;16(2):365-371. doi: 10.4103/jcrt.JCRT_769_18. J Cancer Res Ther. 2020. PMID: 32474525
-
Adenomyosis: An update regarding its diagnosis and clinical features.J Gynecol Obstet Hum Reprod. 2021 Dec;50(10):102228. doi: 10.1016/j.jogoh.2021.102228. Epub 2021 Sep 11. J Gynecol Obstet Hum Reprod. 2021. PMID: 34520877 Review.
-
The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.Eur Rev Med Pharmacol Sci. 2021 May;25(9):3432-3439. doi: 10.26355/eurrev_202105_25823. Eur Rev Med Pharmacol Sci. 2021. PMID: 34002816
-
Transvaginal Ultrasound for the Diagnosis of Adenomyosis: Systematic Review and Meta-Analysis.J Minim Invasive Gynecol. 2018 Feb;25(2):257-264. doi: 10.1016/j.jmig.2017.08.653. Epub 2017 Aug 30. J Minim Invasive Gynecol. 2018. PMID: 28864044
Cited by
-
Analysis of dysmenorrhea-related factors in adenomyosis and development of a risk prediction model.Arch Gynecol Obstet. 2025 Apr;311(4):1081-1089. doi: 10.1007/s00404-025-07967-y. Epub 2025 Mar 17. Arch Gynecol Obstet. 2025. PMID: 40095084 Free PMC article.
-
Diagnostic accuracy of pre-induction cervical elastography, volume, length, and uterocervical angle for the prediction of successful induction of labor with dinoprostone.Arch Gynecol Obstet. 2023 Oct;308(4):1301-1311. doi: 10.1007/s00404-023-07076-8. Epub 2023 May 21. Arch Gynecol Obstet. 2023. PMID: 37210702
-
Perspectives in transvaginal sonography for the diagnosis of adenomyosis.Front Med (Lausanne). 2025 Jun 19;12:1533648. doi: 10.3389/fmed.2025.1533648. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40612584 Free PMC article.
-
Diagnostic value of contrast-enhanced ultrasound in endometrial lesions.BMC Womens Health. 2025 Jul 9;25(1):338. doi: 10.1186/s12905-025-03860-7. BMC Womens Health. 2025. PMID: 40634988 Free PMC article.
-
Application of elastography to diagnose adenomyosis and evaluate the degree of dysmenorrhea: a prospective observational study.Reprod Biol Endocrinol. 2023 Oct 26;21(1):98. doi: 10.1186/s12958-023-01145-y. Reprod Biol Endocrinol. 2023. PMID: 37884924 Free PMC article.
References
-
- Van den Bosch T, Van Schoubroeck D (2018) Ultrasound diagnosis of endometriosis and adenomyosis: State of the art. Best Pract Res Clin Obstet Gynaecol 51:16–24. https://doi.org/10.1016/j.bpobgyn.2018.01.013 - DOI - PubMed
-
- Cunningham RK, Horrow MM, Smith RJ, Springer J (2018) Adenomyosis: a sonographic diagnosis. Radiographics 38(5):1576–1589. https://doi.org/10.1148/rg.2018180080 - DOI - PubMed
-
- Harada T, Khine YM, Kaponis A, Nikellis T, Decavalas G, Taniguchi F (2016) The impact of adenomyosis on women’s fertility. Obstet Gynecol Surv 71(9):557–568. https://doi.org/10.1097/ogx.0000000000000346 - DOI - PubMed - PMC
-
- Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E (2014) Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod 29(5):964–977. https://doi.org/10.1093/humrep/deu041 - DOI - PubMed
-
- Younes G, Tulandi T (2017) Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril 108(3):483-490.e3. https://doi.org/10.1016/j.fertnstert.2017.06.025 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources